OXS-1650

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameOXS-1650
Drug Alias NameCD133KDELdCD133KDELOXS-1650
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionElongation factor 2 inhibitorsAnti-CD133Protein biosynthesis inhibitors
TargetsCD133Elongation factor 2
Therapy Area/IndicationsCarcinoma, Ovarian Epithelial
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Minnesota
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of MinnesotaGt Biopharma Inc
Inactive CompaniesN/A
Active IndicationsCarcinoma, Ovarian Epithelial
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A